1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Summary

The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in US. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of Indonesia in 2014 was approximately 252 million, having grown at a CAGR of 1.7% from 2008. The country’s increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was worth $2.99 billion in 2008 and is projected to reach approximately $6.24 billion by 2014 at a Compound Annual Growth Rate (CAGR) of 12.4%. The overall market is estimated to reach $ 12.6 billion by 2020. New health insurance scheme Jaminan Kesehatan Nasional (JKN) - Universal Health Coverage (UHC) aims to provide health insurance to 250 million people by 2019. The Indonesia medical device market was valued at $793m in 2013 and is projected to grow at a CAGR of 4.9% to an estimated $872m billion in 2020.

These growth trends can be primarily attributed to -
- Improved access to healthcare facilities
- Increase in healthcare insurance coverage

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Kalbe Farma, Tempo Scan Pacific, Kimia Farma, Darya Varia Laboratories and Indofarma and market overview of medical device market.
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Indonesia’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Indonesia’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Indonesia’s healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 17
2.1 GlobalData Report Guidance 17
3 Overview of Pharmaceutical and Medical Device Markets 18
3.1 Pharmaceutical Market 18
3.1.1 Market Overview 18
3.1.2 Supply Channels 21
3.1.3 Market Segments 23
3.1.4 Major Drug Classes 27
3.1.5 Major Players 33
3.2 Medical Device Market 54
3.2.1 Market Overview 54
3.3 Market Drivers and Barriers 57
3.3.1 Drivers 57
3.3.2 Barriers 58
4 Market Access 61
4.1 Reimbursement and Payer Landscape 61
4.1.1 Overview of Healthcare System 61
4.1.2 Reimbursement Process 63
4.1.3 Overview of Insurance Providers 65
4.1.4 Patient Share of Healthcare Expenditure 68
4.1.5 Healthcare Price Trends 69
4.1.6 Pricing Policies 70
4.2 Regulatory Landscape 71
4.2.1 Overview of Regulatory Agencies 71
4.2.2 Market Authorization Procedure for Pharmaceutical Products 72
4.2.3 New Medical Device Approval Process 78
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 79
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 80
4.2.6 Intellectual Property Rights 81
4.2.7 Clinical Trial Regulations 85
4.2.8 Pharmaceutical Advertising Regulations 87
4.2.9 Pharmacy Regulations 87
4.2.10 Labeling and Packaging Regulations 88
5 Country Analysis 89
5.1 Political Environment 89
5.1.1 Political Structure 89
5.1.2 Analysis of the Current Political Environment 90
5.1.3 Healthcare Policy Initiatives 90
5.2 Economic Landscape 92
5.3 Economic Indicators 96
5.3.1 Gross Domestic Product 96
5.3.2 Gross National Income 101
5.3.3 Inflation 102
5.3.4 Currency Exchange Rate 105
5.3.5 Foreign Direct Investment 107
5.3.6 Foreign Exchange Reserves 108
5.3.7 Trade Balance 109
5.3.8 Government Structural Balance 112
5.3.9 Government Gross Debt 113
5.3.10 Major Industries 114
5.4 Demographics 115
5.4.1 Population 115
5.4.2 Education and Literacy 130
5.4.3 Employment 132
5.4.4 Disease Burden 134
5.5 Healthcare Infrastructure 137
5.5.2 Healthcare Parameters 143
5.5.3 Environmental Health 145
5.5.4 Healthcare Personnel 150
5.6 Healthcare Expenditure 153
5.6.1 Overview of Healthcare Expenditure 153
5.6.2 Major Components of Healthcare Expenditure 154
5.6.3 Healthcare Expenditure Distribution 156
5.7 Trade Associations 157
5.7.1 International Pharmaceutical Manufacturers Group 157
5.7.2 Indonesia Pharmaceutical Association 157
5.7.3 Indonesia Medical Association 157
5.8 Trade Fairs 157
6 Opportunities and Challenges 159
6.1 Opportunities 159
6.2 Challenges 161
7 Appendix 163
7.1 Abbreviations 163
7.2 Bibliography 166
7.3 Research Methodology 175
7.3.1 Coverage 176
7.3.2 Secondary Research 176
7.3.3 Forecasts 177
7.3.4 Expert Panel 177
7.4 Disclaimer 177

1.1 List of Tables
Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2015 20
Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015-2020 21
Table 3: Pharmaceutical Market, Indonesia, Distribution Channel Price Margins (%), 2014 22
Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 23
Table 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2014 25
Table 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2014 26
Table 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005 27
Table 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005 29
Table 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005 30
Table 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005 31
Table 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segment (%), 2005 32
Table 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005 33
Table 13: Major Products, PT Kalbe Farma, Revenue, 2014 34
Table 14: Major Products, PT Tempo Scan Pacific, 2014 40
Table 15: Major Products, PT Darya-Varia Laboratoria, 2014 49
Table 16: Major Products, PT Indofarma, 2014 52
Table 17: Medical devices, Imports market size ($m), 2013 55
Table 18: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011 66
Table 19: Overview of Insurance Providers, Indonesia, Public Health Insurance Schemes Overview, 2010 67
Table 20: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008-2014 69
Table 21: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2014 70
Table 22: Regulatory Landscape, Indonesia, New Drug Registration Categories, 2014 74
Table 23: Regulatory Landscape, Indonesia, Patent Application Fees, 2014 83
Table 24: Impact of Natural Calamities, Indonesia, 1996-2009 94
Table 25: Economic Indicators, Indonesia, GDP per Capita ($), 2008-2015 97
Table 26: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016-2020 98
Table 27: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2015 100
Table 28: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016-2020 100
Table 29: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2014 101
Table 30: Economic Indicators, Indonesia, CPI, 2008-2015 103
Table 31: Economic Indicators, Indonesia, Consumer Price Index, Forecast, 2016-2020 103
Table 32: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008-2015 104
Table 33: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016-2020 105
Table 34: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2014 106
Table 35: Economic Indicators, Indonesia, FDI ($bn), 2008-2014 107
Table 36: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2014 108
Table 37: Economic Indicators, Indonesia, Trade balance ($bn), 2008-2014 109
Table 38: Economic Indicators, Indonesia, Imports ($bn), 2008-2014 110
Table 39: Economic Indicators, Indonesia, Exports ($bn), 2008-2014 111
Table 40: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008-2014 112
Table 41: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008-2014 114
Table 42: Economic Indicators, Indonesia, Major industries by GDP share (%), 2014 115
Table 43: Demographics, Indonesia, Population (million), 2008-2015 116
Table 44: Demographics, Indonesia, Population (million), Forecast, 2016-2020 117
Table 45: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2015 118
Table 46: Demographics, Indonesia, Urban and Rural Population Share (%), 2016-2020 119
Table 47: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2015 120
Table 48: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016-2020 121
Table 49: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2014 122
Table 50: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2014 123
Table 51: Demographics, Indonesia, Causes of Mortality (‘000), 2012 125
Table 52: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008-2014 126
Table 53: Demographics, Indonesia, Immunization Rate (%), 2008-2014 127
Table 54: Demographics, Indonesia, Gender Ratio (M/F), 2008-2014 128
Table 55: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2015 129
Table 56: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016-2020 130
Table 57: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2014 131
Table 58: Demographics, Indonesia, School Enrollment by Age Group (%), 2014 132
Table 59: Demographics, Indonesia, Unemployment (%), 2008-2014 133
Table 60: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010 135
Table 61: Demographics, Indonesia, DALY (Per 100,000 Population), 2004 137
Table 62: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2014 138
Table 63: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008-2014 139
Table 64: Healthcare Infrastructure, Indonesia, Hospitals by Type of Care, 2014 141
Table 65: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008-2014 142
Table 66: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008-2014 143
Table 67: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2014 144
Table 68: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2014 146
Table 69: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008-2014 147
Table 70: Environmental Health, Indonesia, Access to Protected Drinking Water (%), 2013 148
Table 71: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008 149
Table 72: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2014 151
Table 73: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008-2014 151
Table 74: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008-2014 152
Table 75: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008-2014 154
Table 76: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008 155
Table 77: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008-2014 156
Table 78: Trade Fairs, Indonesia, Major Healthcare Trade Fairs, 2013-2014 158

1.2 List of Figures
Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2015 20
Figure 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015-2020 21
Figure 3: Pharmaceutical Market, Indonesia, Distribution Chain, 2014 22
Figure 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 23
Figure 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2014 25
Figure 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2014 26
Figure 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005 27
Figure 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005 28
Figure 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005 29
Figure 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005 30
Figure 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segments (%), 2005 31
Figure 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005 33
Figure 13:Medical Device , Imports market size, 2013 56
Figure 14: Healthcare Market, Indonesia, Drivers and Barriers, 2014 60
Figure 15: Market Access, Indonesia, History of Health Insurance System, 1968-2014 62
Figure 16: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2014 64
Figure 17: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011 65
Figure 18: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008-2014 69
Figure 19: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2014 70
Figure 20: Regulatory Landscape, Indonesia, Structure of the National Agency of Drug and Food Control, 2014 72
Figure 21: Regulatory Landscape, Indonesia, New Drug Market Authorization Process, 2014 75
Figure 22: Regulatory Landscape, Indonesia, Generic Drug Market Authorization Process, 2014 77
Figure 23: Regulatory Landscape, Indonesia, Medical Device Approval Process, Indonesia, 2014 79
Figure 24: Regulatory Landscape, Indonesia, Licensing Process for Manufacturing, 2014 80
Figure 25: Regulatory Landscape, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2014 82
Figure 26: Regulatory Landscape, Indonesia, Patent Approval Process, 2014 84
Figure 27: Regulatory Landscape, Indonesia, Clinical Trial Regulation Process, 2014 86
Figure 28: Economic Indicators, Indonesia, GDP Per Capita ($), 2008-2015 97
Figure 29: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016-2020 98
Figure 30: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2015 99
Figure 31: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016-2020 100
Figure 32: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2014 101
Figure 33: Economic Indicators, Indonesia, CPI, 2008-2015 102
Figure 34: Economic Indicators, Indonesia, CPI, Forecast, 2016-2020 103
Figure 35: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008-2015 104
Figure 36: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016-2020 105
Figure 37: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2014 106
Figure 38: Economic Indicators, Indonesia, FDI ($bn), 2008-2014 107
Figure 39: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2014 108
Figure 40: Economic Indicators, Indonesia, Trade Balance ($bn), 2008-2014 109
Figure 41: Economic Indicators, Indonesia, Imports ($bn), 2008-2014 110
Figure 42: Economic Indicators, Indonesia, Exports ($bn), 2008-2014 111
Figure 43: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008-2014 112
Figure 44: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008-2014 113
Figure 45: Economic Indicators, Indonesia, Major Industries by GDP Share (%), 2014 114
Figure 46: Demographics, Indonesia, Population (million), 2008-2015 116
Figure 47: Demographics, Indonesia, Population (million), Forecast, 2016-2020 117
Figure 48: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2015 118
Figure 49: Demographics, Indonesia, Urban and Rural Population Share (%), 2016-2020 119
Figure 50: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2015 120
Figure 51: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016-2020 121
Figure 52: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2014 122
Figure 53: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2014 123
Figure 54: Demographics, Indonesia, Causes of Mortality (‘000), 2012 124
Figure 55: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008-2014 126
Figure 56: Demographics, Indonesia, Immunization Rate (%), 2008-2014 127
Figure 57: Demographics, Indonesia, Gender Ratio (M/F), 2008-2014 128
Figure 58: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2015 129
Figure 59: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016-2020 130
Figure 60: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2014 131
Figure 61: Demographics, Indonesia, School Enrollment by Age Group (%), 2014 132
Figure 62: Demographics, Indonesia, Unemployment (%), 2008-2014 133
Figure 63: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010 134
Figure 64: Demographics, Indonesia, DALYs (Per 100,000 Population), 2004 136
Figure 65: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2014 138
Figure 66: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008-2014 139
Figure 67: Healthcare Infrastructure, Indonesia, Number of Hospitals by Type of Care, 2014 140
Figure 68: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008-2014 142
Figure 69: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008-2014 143
Figure 70: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2014 144
Figure 71: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2014 146
Figure 72: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008-2014 147
Figure 73: Environmental Health, Indonesia, Access to Protected Drinking Water, 2013 148
Figure 74: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008 149
Figure 75: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2014 150
Figure 76: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008-2014 151
Figure 77: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008-2013 152
Figure 78: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008-2014 154
Figure 79: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008 155
Figure 80: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008-2014 156
Figure 81: Healthcare Market, Indonesia, Opportunities and Challenges, 2014 162

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.